Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

aTYR PHARMA INC (ATYR) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

aTYR PHARMA INC (ATYR), most recent 12 months reported: revenue $190K, net loss $60.81M, free cash flow -$54.82M. Latest balance sheet on file: liquid cash $57.42M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): Pluri Inc. · ProKidney Corp. · ImageneBio, Inc. · CARDIFF ONCOLOGY, INC. · VivoSim Labs, Inc. · AIM ImmunoTech Inc. · INMUNE BIO INC. · Senti Biosciences Holdings, Inc.

Stock screener

Watchlist